Table 2.
Clinical and treatment characteristics of PMHC clients who participated in the study, in total and for each sub-sample analyseda
| Total sample (n = 1532) | ≥ 2 sessions (n = 1295) | ≥ 2 sessions and problems ≥ 6 months (n = 1059) |
|
|---|---|---|---|
| Client-reported clinical and treatment characteristics | |||
| Data completeness (%) | > 95% | > 95% | > 95% |
| Variable | Estimate | Estimate | Estimate |
| Duration of psychological problems prior to initial assessment ≥6 months, % (n) | 84.3 (1228) | 84.0 (1059) | 100.0 (1059) |
| Previous treatment attempts last 12 monthsb | 15.9 (244) | 16.5 (213) | 17.9 (190)* |
| Caseness at baseline, % (n) | |||
| PHQ ≥ 10 | 67.2 (1019) | 66.2 (856)* | 67.2 (712) |
| GAD ≥8 | 65.0 (985) | 64.5 (835) | 64.6 (648) |
| PHQ ≥ 10 OR GAD ≥8 | 77.2 (1172) | 76.8 (994) | 77.4 (820) |
| Medication use, % (n)c | |||
| Antidepressant, daily | 13.6 (187) | 13.9 (164) | 14.2 (138) |
| Anxiolytic, weekly | 8.9 (120) | 8.4 (98) | 8.5 (81) |
| Sleep, weekly | 12.5 (171) | 12.5 (148) | 12.5 (120) |
| Therapist-reported clinical and treatment characteristics | |||
| Data completeness, % (n) | 75.1 (1150) | 85.7 (1110)d | 85.4 (905) |
| Variable | Estimate | Estimate | Estimate |
| Referral, % (n) | |||
| GP or other health personnel | 57.0 (655) | 56.7 (629) | 57.4 (519) |
| Self | 43.0 (495) | 43.3 (481) | 42.7 (386) |
| Tentative primary diagnosis, % (n) | |||
| Major depressive disorder | 45.2 (520) | 45.1 (500) | 47.2 (427)** |
| Panic disorder with agoraphobia | 4.1 (47) | 4.1 (46) | 4.2 (38) |
| Panic disorder without agoraphobia | 4.6 (53) | 4.7 (52) | 3.5 (32) |
| Social anxiety disorder | 5.2 (60) | 5.1 (57) | 5.4 (49) |
| Hypochondria | 2.7 (31) | 2.8 (31) | 2.9 (26) |
| Generalized anxiety disorder | 3.4 (39) | 3.3 (37) | 3.4 (31) |
| Posttraumatic stress syndrome (PTSD) | 1.0 (12) | 1.1 (12) | 0.9 (8) |
| Obsessive compulsive disorder | 0.5 (6) | 0.5 (6) | 0.3 (3) |
| Mixed anxiety and depression | 20.2 (232) | 20.4 (226) | 20.2 (183) |
| Other | 13.1 (150) | 12.9 (143) | 11.9 (108) |
| Waiting times, median (IQR) | |||
| Days between initial contact and assessment | 10.0 (4.0–22.0) | 11.0 (4.0–23.0) | 12.0 (4.0–24.0) |
| Days between assessment and first treatment session | 8.0 (4.0–15.0) | 8.0 (4.0–15.0) | 8.0 (4.0–15.0) |
| Days between initial contact and first treatment session | 22.0 (12.0–41.0) | 22.0 (12.0–41.0) | 23.0 (13.0–42.0) |
| Treatment duration, median (IQR) | |||
| Number of attended sessions | 6.0 (4.0–9.0) | 6.0 (4.0–9.0) | 6.0 (4.0–9.0) |
| Number of weeks | 11.1 (5.4–19.0) | 11.1 (5.4–19.0) | 11.1 (5.8–19.3) |
| Type of treatment | |||
| Proportion of total number of registered sessions by mode of treatment (≈7000 sessions), % | |||
| Guided self-help | 8.3 | 8.4 | 8.0 |
| Group course psychoeducation | 16.5 | 16.7 | 16.9 |
| Face-to-face | 71.3 | 72.1 | 72.1 |
| Proportion of clients that during the course of treatment used mode of treatment, % | |||
| Guided self-help | 16.9 | 17.1 | 16.7 |
| Group course psychoeducation | 21.5 | 22.1 | 22.3 |
| Face-to-face | 76.6 | 77.8 | 77.3 |
aDispersed numbers due to missing data
bby psychologist or psychiatrist
cData completeness ≈ 90%.s
dTherapist questionnaires available for n = 1202 (92.8%), but information about the characteristics reported in this table was missing for n = 92
Distribution different from the comparison sample at *p < 0.05,** p < 0.01, and *** p < 0.001. Differences examined using chi-square tests